Evaluation of safety and efficacy of skin care formulatio

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1.Indian / Asian female subjects

2.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)

3.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarÃ¢â?¬Â¦.) Specific criteria

4.43 normal skin volunteers +13 sensitive skin (declared through lactic acid sting test).

5.Having wheatish to dark complexion.

6.Having visible dry skin.

Exclusion Criteria

1 Being pregnant or breastfeeding or having stopped to breastfeed in the past three months

2 Having refused to give her assent by not signing the consent form

3 Taking part in another study liable to interfere with this study

4 Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)

5 Having a progressive asthma (either under treatment or last fit in the last 2 years)

6 Being epileptic.

7 Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)

8 Having cutaneous hypersensitivity

9 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.

10 Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)

11 Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

12 Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit

13 Having applied a cosmetic product (included make-up) or skin care product on the studied areas the day of the study (only face cleaned with water is accepted)

14 Refusing to follow the restrictions below during the study: -Do not take part in any family planning activities leading to pregnancy and breastfeeding -Do not take part in another study liable to interfere with this study. -Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). -Do not change her cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit. -During the study: Do not use other cosmetic products or skin care products other than the tested products to the studied areas. (only standard facewash is accepted). The day of the measurements: No test product must be used (only face cleaned with water is accepted) Specific criteria

15 Having started, changed or interrupted one hormonal treatment (hormonal contraception, Hormone Replacement Therapy) during the past 3 months.

16 Having started, changed or stopped his/her tobacco consumption (for smokers consuming more than 10 cigarettes per day) in the previous 6 months

17 Having taken a medicinal treatment which could lead to hyper pigmentation (phenytoÃ?Â¯n, amiodarone, metals, minocyclineÃ¢â?¬Â¦) in the previous 6 months

18 Taking oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta caroteneÃ¢â?¬Â¦)

19 Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask Ã¢â?¬Â¦) or having applied self-tanning products in the week preceding the start of the study

20 Having applied products with anti-wrinkle action (Retinoic acid, retinol, retinaldehyde, isotretinoin, A.H.A...) in the 2 weeks preceding the start of the study

21 Having applied products with a depigmenting action (hydroquinone or derivatesÃ¢â?¬Â¦) in the 4 weeks preceding the start of the study.

22 Having undergone physical and/or chemical treatments of the spots (liquid nitrogen, dry ice, pulsed flash

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
skin brightening, skin safetyTimepoint: Baseline, 30 min after product application, 7 days, 14 days and 28 days

Secondary Outcome Measures

Name	Time	Method
Improvement in Skin <br/ ><br>Water Barrier Function and in Skin SmoothnessTimepoint: Baseline, 30 min after product application, 7 days, 14 days and 28 days